海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
4956件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old
- Alzheimer's Disease;Alzheimer's Disease;Alzheimer's Disease;Alzheimer's Disease
- Spain
- 2014-07-15
Not Recruiting
- The relationship between apolipoprotein E-Epsilon 4 polymorphism and postoperative cognitive dysfunction in old adults undergoing total intravenous anesthesia and sevoflurane anesthesia
- postoperative cognitive dysfunction in old adults
- China
- 2015-06-14
Not recruiting
- Does Incorporation of EPA and DHA in Lipoproteins Differ According to Apolipoprotein E Genotype?
- Healthy
- Canada
- 2012-02-24
Not recruiting
- Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration
- Dementia of the Alzheimer Type;Age-related Cognitive Decline;Mild Cognitive Impairment Due to Alzheimer Disease
- Canada
- 2016-02-23
Not recruiting
- Apolipoprotein E driven therapeutics for Alzheimer’s disease
- Alzheimer's Disease
- Australia
- 2013-04-24
Not Recruiting
- Correlation analysis of SLCO1B1 and APOE polymorphisms with atorvastatin lipid-lowering effect and toxic and side effects
- hyperlipemia
- China
- 2018-09-30
Not recruiting
- Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012
- Hyperlipidemias;Hypertension
- Korea, Republic of
- 2018-05-28
Not recruiting
- Cerament Treatment of Fracture Defects
- AO 41-B2 and AO 41-B3 Tibia Fractures
- Germany
- 2013-04-04
Not recruiting
- Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study
- Contraception
- United Kingdom
- 2018-04-19
Not Recruiting
- Randomized study to assess the added value of Laromustine in combination with standard remission-induction chemotherapy in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or myelodysplasia (MDS) (RAEB with IPSS = 1.5) - HOVON 92 AML
- AML according to WHO classification (excluding acute promyelocytic leukaemia) or refractory anemia with excess of blasts (RAEB) and IPSS score =1.5 or therapy-related AML/RAEB or biphenotypic leukemia MedDRA version: 9.1 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia MedDRA version: 9.1 Level: LLT Classification code 10054593 Term: Refractory anemia with excess blasts in transformation
- Belgium, Netherlands
- 2008-06-06